Advisor Group Holdings, Inc. Gossamer Bio, Inc. Transaction History

Advisor Group Holdings, Inc.

$39.8 Billion
Q4 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 1,349 shares of GOSS stock, worth $1,591. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,349

Previous 1,349 -0.0%

Holding current value

$1,591

Previous $1,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$0.51 - $1.27 $459 - $1,143	900 Added 200.45%	1,349 $1,000
Q1 2024 May 10, 2024	BUY	$0.8 - $1.51 $43 - $81	54 Added 13.67%	449 $0
Q4 2023 Feb 12, 2024	SELL	$0.48 - $1.08 $98 - $221	-205 Reduced 34.17%	395 $0
Q3 2023 Nov 13, 2023	BUY	$0.78 - $1.82 $234 - $546	300 Added 100.0%	600 $0
Q2 2023 Aug 10, 2023	SELL	$0.98 - $1.53 $543 - $849	-555 Reduced 64.91%	300 $0
Q1 2023 May 12, 2023	BUY	$0.96 - $2.92 $181 - $551	189 Added 28.38%	855 $1,000
Q4 2022 Feb 10, 2023	BUY	$1.74 - $12.87 $560 - $4,144	322 Added 93.6%	666 $1,000
Q2 2022 Aug 10, 2022	SELL	$5.97 - $9.97 $15,820 - $26,420	-2,650 Reduced 88.51%	344 $3,000
Q1 2022 May 04, 2022	SELL	$8.44 - $12.49 $9,900 - $14,650	-1,173 Reduced 28.15%	2,994 $26,000
Q3 2021 Nov 05, 2021	BUY	$7.25 - $13.23 $4,350 - $7,938	600 Added 16.82%	4,167 $52,000
Q2 2021 Aug 02, 2021	BUY	$8.0 - $9.75 $18,800 - $22,912	2,350 Added 193.1%	3,567 $29,000
Q1 2021 May 13, 2021	SELL	$8.63 - $10.94 $138 - $175	-16 Reduced 1.3%	1,217 $11,000
Q4 2020 Feb 10, 2021	SELL	$8.3 - $13.59 $1,660 - $2,718	-200 Reduced 13.96%	1,233 $12,000
Q3 2020 Nov 12, 2020	BUY	$11.3 - $14.75 $5,650 - $7,375	500 Added 53.59%	1,433 $17,000
Q2 2020 Aug 14, 2020	BUY	$9.52 - $15.98 $142 - $239	15 Added 1.63%	933 $12,000
Q1 2020 May 18, 2020	BUY	$8.0 - $15.48 $7,344 - $14,210	918 New	918 $9,000

Others Institutions Holding GOSS

# of Institutions

116

Shares Held

163M

Call Options Held

821K

Put Options Held

557K

View Full List

About Gossamer Bio, Inc.

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $111M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

More about GOSS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Gossamer Bio, Inc. Transaction History